Try our beta test site
Trial record 1 of 17 for:    ketamine bipolar disorder
Previous Study | Return to List | Next Study

Intranasal Ketamine In the Treatment of Pediatric Bipolar Disorder (IKBP)

This study has been terminated.
(Administrative issues)
Sponsor:
Information provided by (Responsible Party):
Juvenile Bipolar Research Foundation
ClinicalTrials.gov Identifier:
NCT01504659
First received: January 3, 2012
Last updated: March 14, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2016
  Primary Completion Date: November 2016 (Final data collection date for primary outcome measure)